Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Latterell Venture Partners
company
About
Latterell Venture Partners is a venture capital firm specializing in startups and early stage healthcare companies.
- 1 - 10
Highlights
Details
- Industries
- Finance,Financial Services,Venture Capital
- Founded date
- Jan 1, 2001
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Investor Type
- Venture Capital
Latterell Venture Partners is a venture capital firm specialized in startups and early stage healthcare companies, including biotechnology, pharmaceutical, research instrument, biomaterial, medical device, healthcare IT, and diagnostic ventures.The firm invests in early stage healthcare companies with innovative technologies, large market opportunities, and passionate entrepreneurs. It offers a collection of venture capital, entrepreneurial, technical, clinical, and collaborative skills enabling entrepreneurs to create successful startups.Founded in 2001, Latterell Venture Partners is based in San Francisco, California.
Investments
Number of Investments
Number of Lead Investments
5
0
Latterell Venture Partners has made 5 investments. Their most recent investment was on
Apr 2, 2014, when Transcend Medical raised $29M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Apr 2, 2014
Transcend Medical
|
Series C | $29M | Health Care | — |
|
Jan 17, 2012
Transcend Medical
|
Series B | $16M | Health Care | — |
|
Jun 15, 2011
Transcend Medical
|
Series B | $51M | Health Care | — |
|
Jun 1, 2009
Transcend Medical
|
Series B | $35M | Health Care | — |
|
Jun 22, 2007
Evoke Pharma
|
Series A | $3.29M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
